Imatinib Mesylate
100 mg/1 · Tablet
By Qilu Pharmaceutical Co., Ltd.
Tablet · 100 mg
- NDC
- 67184-0532
- Route
- Oral
- Therapeutic class
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor
- Marketing category
- ANDA
Package sizes
- 30 BLISTER PACK in 1 CARTON (67184-0532-3) / 10 TABLET in 1 BLISTER PACKNDC 67184-0532-3Available to Order
- 90 TABLET in 1 BOTTLE (67184-0532-1)NDC 67184-0532-1Available to Order
- 500 TABLET in 1 BOTTLE (67184-0532-2)NDC 67184-0532-2Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Oncology & Specialty
See all →Verzenio (Abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to Source
